PVCT stock
Provectus Biopharmaceuticals Inc (PVCT) valuation · $25.9M cap
Provectus Biopharmaceuticals Inc (PVCT) $25.9M cap.
| Metric | Value |
|---|---|
| Market cap | $25.9M |
| Revenue | $336.1K |
| P/S | 77.2 |
| P/B | 5.4 |
PVCT valuation FAQ
What is PVCT's market cap?
Provectus Biopharmaceuticals Inc (PVCT) market cap is $25.9M on the latest cached fundamentals snapshot.
What is PVCT's latest revenue?
Latest cached Provectus Biopharmaceuticals Inc (PVCT) revenue was $336.1K. Statements: https://lician.com/financials/pvct
What is PVCT's price-to-sales ratio?
Provectus Biopharmaceuticals Inc (PVCT) price-to-sales (P/S) is 77.2, cached market cap $25.9M divided by revenue $336.1K.
What is PVCT's price-to-book ratio?
Provectus Biopharmaceuticals Inc (PVCT) price-to-book (P/B) is 5.4 on the latest cached fundamentals snapshot.
How many PVCT valuation scalars are listed on this page?
This page lists 4 cached valuation scalars for Provectus Biopharmaceuticals Inc (PVCT): Market cap, Revenue, P/S, and P/B.
Where is PVCT valuation listed?
Cached valuation multiples for Provectus Biopharmaceuticals Inc (PVCT) are listed at https://lician.com/valuation/pvct.
Not investment advice. Figures as filed or reported, not a live feed.